MDxHealth SA (MDXH.BR) Forecast, Price Target & Analyst Ratings
EBR:MDXH • BE0974461940
3.02 EUR
-0.12 (-3.76%)
Last: Dec 15, 2023, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MDxHealth SA (MDXH.BR).
Forecast Snapshot
Consensus Price Target
€8.40
+ 178.05% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2023
EPS Estimate-$2.09
Revenue Estimate19.605M
ChartMill Buy Consensus
86.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€8.40
Upside
+ 178.05%
From current price of €3.02 to mean target of €8.40, Based on 9 analyst forecasts
Low
€5.87
Median
€6.42
High
€15.25
Price Target Revisions
1 Month
814.71%
3 Months
814.71%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for MDXH.BR. The average price target is 8.4 EUR. This implies a price increase of 178.05% is expected in the next year compared to the current price of 3.02.
The average price target has been revised upward by 814.71% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.67%
MDXH.BR was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MDXH.BR.
In the previous month the buy percentage consensus was at a similar level.
MDXH.BR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2023
EPS Estimate-$2.09
Revenue Estimate19.605M
Revenue Q2Q-18.48%
EPS Q2Q-90.09%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.46M 56.57% | 22.24M 20.48% | 37.05M 66.59% | 70.745M 90.94% | 83.282M 17.72% | 112.2M 34.72% | 113.21M 0.90% | 129.96M 14.80% | |
| EBITDA YoY % growth | -23.52M 29.71% | -23.8M -1.19% | -32.95M -38.45% | -21.782M 33.89% | -12.427M 42.95% | -1.924M 84.52% | 11.985M 723.01% | 26.508M 121.18% | |
| EBIT YoY % growth | -26.85M 27.20% | -26.84M 0.04% | -37.86M -41.06% | -27.384M 27.67% | -20.914M 23.63% | -10.779M 48.46% | 3.96M 136.74% | 18.072M 356.36% | |
| Operating Margin | -145.45% | -120.68% | -102.19% | -38.71% | -25.11% | -9.61% | 3.50% | 13.91% | |
| EPS YoY % growth | N/A 12.92% | N/A -363.99% | -0.10 99.44% | -6.62 -6,519.80% | -5.18 21.73% | -0.34 93.50% | 0.10 129.09% | 0.61 521.98% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.09 -90.09% | -2.09 -4,082.00% | -1.89 -529.00% | -1.84 -359.00% | -1.58 24.39% |
| Revenue Q2Q % growth | 19.605M -18.48% | 18.423M 25.33% | 20.128M -36.00% | 20.766M 7.32% | 23.931M 22.07% |
| EBITDA Q2Q % growth | -5.576M 65.08% | -4.846M 31.52% | -4.28M 67.20% | -4.243M -689.33% | -3.848M 30.99% |
| EBIT Q2Q % growth | -7.417M 64.48% | -6.415M 26.41% | -6.333M 61.53% | -6.129M -34.40% | -2.618M 64.71% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-49.87%
EPS Next 5 Year
51.91%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
43.11%
Revenue Next 5 Year
27.69%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.82%
EBIT Next 5 Year
22.55%
MDxHealth SA / MDXH.BR Forecast FAQ
Can you provide the average price target for MDxHealth SA stock?
9 analysts have analysed MDXH.BR and the average price target is 8.4 EUR. This implies a price increase of 178.05% is expected in the next year compared to the current price of 3.02.
What are the consensus estimates for MDxHealth SA (MDXH.BR) next earnings?
The consensus EPS estimate for the next earnings of MDxHealth SA (MDXH.BR) is -2.09 EUR and the consensus revenue estimate is 19.61M EUR.
How many analysts cover MDxHealth SA (MDXH.BR) stock?
The number of analysts covering MDxHealth SA (MDXH.BR) is 9.